Pages
- About Biohaven
- Homepage
- Board of Directors
- Management and Clinical Operations
- Scientific Advisory Board
- Intellectual Property
- CGRP RECEPTOR ANTAGONIST PLATFORM
- Therapeutic Focus
- Contact
- Investigator Initiated Research
- Pipeline
- Privacy Policy
- Terms & Conditions
- Sitemap
- Glutamate Modulation Platform
- BHV-3500
- CGRP’s Role in Migraine
- Glutamate’s Role in the Brain
- RIMEGEPANT
- Trigriluzole
- BHV-0223 – for Amyotrophic Lateral Sclerosis (ALS)
- BHV-5000 – LOW-TRAPPING NMDA ANTAGONIST
- Limitations of Current Therapy
- Temp glutamate page
- Expanded Access Policy Position
